Search research articles
Contact Us
Filters
Showing results (951-960 of 1,171) with videos related to
Page
of 118
Sort By:
Brain, Behavior, and Immunity
|
May 17, 2020
Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection
Claudio Liguori, Mariangela Pierantozzi, Matteo Spanetta, et al.
Journal of Cellular and Molecular Medicine
|
September 8, 2022
Expression analysis of miRNA hsa-let7b-5p in naso-oropharyngeal swabs of COVID-19 patients supports its role in regulating ACE2 and DPP4 receptors
Andrea Latini, Chiara Vancheri, Francesca Amati, et al.
Plos One
|
May 16, 2017
Infectious disease ward admission positively influences P. jiroveci pneumonia (PjP) outcome: A retrospective analysis of 116 HIV-positive and HIV-negative immunocompromised patients
Alessandra Ricciardi, Elisa Gentilotti, Luigi Coppola, et al.
Hepatology (Baltimore, Md.)
|
September 26, 2002
A randomized 4-arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C relapsing after interferon monotherapy
Giorgio Saracco, Alda Olivero, Alessia Ciancio, et al.
Minerva Medica
|
June 30, 1983
[Microbiological, kinetic and clinical study on a new cephamycin: cefotetan]
M L Soranzo, E Capra, M Eandi, et al.
Nature Materials
|
November 29, 2017
Programmed coherent coupling in a synthetic DNA-based excitonic circuit
Étienne Boulais, Nicolas P D Sawaya, Rémi Veneziano, et al.
Journal of Hepatology
|
October 30, 2001
Interferon and amantadine in combination as initial treatment for chronic hepatitis C patients
M Tabone, C Laudi, B Delmastro, et al.
Antiviral Therapy
|
April 28, 2006
Antiviral efficacy and genotypic resistance patterns of combination therapy with stavudine/tenofovir in highly active antiretroviral therapy experienced patients
Andrea Antinori, Maria Paola Trotta, Paola Nasta, et al.
Plos One
|
March 12, 2019
Role of pretreatment variables on plasma HIV RNA value at the sixth month of antiretroviral therapy including all first line drugs in HIV naïve patients: A path analysis approach
Carlo Mengoli, Monica Basso, Samantha Andreis, et al.
Journal of Medical Virology
|
April 17, 2013
Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice
R Salpini, C Alteri, V Cento, et al.
Page
of 118
Search research articles
Search
Showing results (951-960 of 1,171) with videos related to
Sort By:
Page
of 118
Brain, Behavior, and Immunity
|
May 17, 2020
Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection
Claudio Liguori, Mariangela Pierantozzi, Matteo Spanetta, et al.
Journal of Cellular and Molecular Medicine
|
September 8, 2022
Expression analysis of miRNA hsa-let7b-5p in naso-oropharyngeal swabs of COVID-19 patients supports its role in regulating ACE2 and DPP4 receptors
Andrea Latini, Chiara Vancheri, Francesca Amati, et al.
Plos One
|
May 16, 2017
Infectious disease ward admission positively influences P. jiroveci pneumonia (PjP) outcome: A retrospective analysis of 116 HIV-positive and HIV-negative immunocompromised patients
Alessandra Ricciardi, Elisa Gentilotti, Luigi Coppola, et al.
Hepatology (Baltimore, Md.)
|
September 26, 2002
A randomized 4-arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C relapsing after interferon monotherapy
Giorgio Saracco, Alda Olivero, Alessia Ciancio, et al.
Minerva Medica
|
June 30, 1983
[Microbiological, kinetic and clinical study on a new cephamycin: cefotetan]
M L Soranzo, E Capra, M Eandi, et al.
Nature Materials
|
November 29, 2017
Programmed coherent coupling in a synthetic DNA-based excitonic circuit
Étienne Boulais, Nicolas P D Sawaya, Rémi Veneziano, et al.
Journal of Hepatology
|
October 30, 2001
Interferon and amantadine in combination as initial treatment for chronic hepatitis C patients
M Tabone, C Laudi, B Delmastro, et al.
Antiviral Therapy
|
April 28, 2006
Antiviral efficacy and genotypic resistance patterns of combination therapy with stavudine/tenofovir in highly active antiretroviral therapy experienced patients
Andrea Antinori, Maria Paola Trotta, Paola Nasta, et al.
Plos One
|
March 12, 2019
Role of pretreatment variables on plasma HIV RNA value at the sixth month of antiretroviral therapy including all first line drugs in HIV naïve patients: A path analysis approach
Carlo Mengoli, Monica Basso, Samantha Andreis, et al.
Journal of Medical Virology
|
April 17, 2013
Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice
R Salpini, C Alteri, V Cento, et al.
Page
of 118